{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:18:46Z","timestamp":1768526326149,"version":"3.49.0"},"reference-count":32,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T00:00:00Z","timestamp":1477008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Jes\u00fas Gangoiti Barrera Foundation","award":["Without number"],"award-info":[{"award-number":["Without number"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Fragile X-associated tremor\/ataxia syndrome (FXTAS) and fragile X-associated primary ovarian insufficiency (FXPOI) are definitely related to the fragile X mental retardation 1 (FMR1) premutation (PM). Additional medical problems have also been associated with the PM, such as fibromyalgia, endocrine, and psychiatric disorders. To improve our understanding in the field, we reviewed all PM carriers and their reasons for any medical referrals from 104 fragile X families molecularly diagnosed in our laboratory and living in the Spanish Basque Country. After signing the written informed consent, we studied their electronic medical records in order to identify the disorders associated with the PM and their frequencies. We obtained clinical data in 188 PM carriers (147 women and 41 men). In women, the frequency of FXPOI (22.61%) was similar to that previously reported in PM carriers. In men, the frequency of definite FXTAS (28.57%) was lower than reported elsewhere. Furthermore, thyroid pathology was associated with the PM, the frequency of hypothyroidism being much higher in the studied region than in the general population (8.84% vs. 0.93%). Finally, we found no association with fibromyalgia or psychiatric problems. These findings represent another population contribution in this field and may be useful for the clinical management of PM carriers.<\/jats:p>","DOI":"10.3390\/genes7100090","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T10:15:16Z","timestamp":1477044916000},"page":"90","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Associated Clinical Disorders Diagnosed by Medical Specialists in 188 FMR1 Premutation Carriers Found in the Last 25 Years in the Spanish Basque Country: A Retrospective Study"],"prefix":"10.3390","volume":"7","author":[{"given":"Sonia","family":"Merino","sequence":"first","affiliation":[{"name":"Molecular Genetics Laboratory, Genetics Service, BioCruces Health Research Institute, Cruces University Hospital, 48903-Barakaldo-Bizkaia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nekane","family":"Ibarluzea","sequence":"additional","affiliation":[{"name":"Molecular Genetics Laboratory, Genetics Service, BioCruces Health Research Institute, Cruces University Hospital, 48903-Barakaldo-Bizkaia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiart","family":"Maortua","sequence":"additional","affiliation":[{"name":"Molecular Genetics Laboratory, Genetics Service, BioCruces Health Research Institute, Cruces University Hospital, 48903-Barakaldo-Bizkaia, Spain"},{"name":"Clinical Group Affiliated with the Centre for Biomedical Research on Rare Diseases (CIBERER), 46010-Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"Prieto","sequence":"additional","affiliation":[{"name":"Human Reproduction Unit, Obstetrics and Gynecology Department, BioCruces Health Research Institute, Cruces University Hospital, 48903-Barakaldo-Bizkaia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idoia","family":"Rouco","sequence":"additional","affiliation":[{"name":"Ataxias and Spastic Paraplegias Unit, Neurology Department, BioCruces Health Research Institute, Cruces University Hospital, 48903-Barakaldo-Bizkaia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Asunci\u00f3n","family":"L\u00f3pez-Ar\u00edztegui","sequence":"additional","affiliation":[{"name":"Clinical Group Affiliated with the Centre for Biomedical Research on Rare Diseases (CIBERER), 46010-Valencia, Spain"},{"name":"Genetics Counseling, Genetics Service, BioCruces Health Research Institute, Cruces University Hospital, 48903-Barakaldo-Bizkaia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7334-1864","authenticated-orcid":false,"given":"Maria-Isabel","family":"Tejada","sequence":"additional","affiliation":[{"name":"Molecular Genetics Laboratory, Genetics Service, BioCruces Health Research Institute, Cruces University Hospital, 48903-Barakaldo-Bizkaia, Spain"},{"name":"Clinical Group Affiliated with the Centre for Biomedical Research on Rare Diseases (CIBERER), 46010-Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2016,10,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Hagerman, R.J., and Hagerman, P.J. (2002). Fragile X Syndrome: Diagnosis, Treatment and Research, The John Hopkins University Press. [3rd ed.].","DOI":"10.56021\/9780801868436"},{"key":"ref_2","unstructured":"Tejada, M.I. (2006). S\u00edndrome X Fr\u00e1gil: Libro de Consulta Para Familias Y Profesionales, Centro Espa\u00f1ol de Documentaci\u00f3n sobre Discapacidad, del Real Patronato sobre Discapacidad. [1st ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"195793","DOI":"10.1155\/2014\/195793","article-title":"Molecular testing for fragile X: Analysis of 5062 tests from 1105 fragile X families\u2014Performed in 12 clinical laboratories in spain","volume":"2014","author":"Tejada","year":"2014","journal-title":"Biomed Res. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1126\/science.1675488","article-title":"Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n","volume":"252","author":"Kremer","year":"1991","journal-title":"Science"},{"key":"ref_5","first-page":"219","article-title":"Clinical guideline of gene FMR1-associated diseases: Fragile X syndrome, primary ovarian insufficiency and tremor-ataxia syndrome","volume":"142","author":"Mila","year":"2014","journal-title":"Med. Clin. Barc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1086\/302720","article-title":"Elevated levels of FMR1 mRNA in carrier males: A new mechanism of involvement in the fragile-X syndrome","volume":"66","author":"Tassone","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/gme.0b013e3181647762","article-title":"Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome","volume":"15","author":"Tejada","year":"2008","journal-title":"Menopause"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/nyas.12693","article-title":"Fragile X-associated tremor\/ataxia syndrome","volume":"1338","author":"Hagerman","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1866-1955-6-26","article-title":"Use of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI)","volume":"6","author":"Sherman","year":"2014","journal-title":"J. Neurodev. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ajmg.a.32060","article-title":"Expanded clinical phenotype of women with the FMR1 premutation","volume":"146A","author":"Coffey","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/ejhg.2009.51","article-title":"Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families","volume":"17","author":"Madrigal","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.291.4.460","article-title":"Penetrance of the fragile X-associated tremor\/ataxia syndrome in a premutation carrier population","volume":"291","author":"Jacquemont","year":"2016","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1866-1955-6-31","article-title":"Emerging topics in FXTAS","volume":"6","author":"Hall","year":"2014","journal-title":"J. Neurodev. Disord."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-013-1138-1","article-title":"Fragile X-associated tremor\/ataxia syndrome (FXTAS): Pathology and mechanisms","volume":"126","author":"Hagerman","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S1474-4422(13)70125-X","article-title":"Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor\/ataxia syndrome","volume":"12","author":"Hagerman","year":"2013","journal-title":"Lancet Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jns.2015.03.031","article-title":"Fragile X premutation carriers: A systematic review of neuroimaging findings","volume":"352","author":"Brown","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1212\/01.wnl.0000269781.10417.7b","article-title":"Volumetric brain changes in females with fragile X-associated tremor\/ataxia syndrome (FXTAS)","volume":"69","author":"Adams","year":"2007","journal-title":"Neurology"},{"key":"ref_18","first-page":"1757","article-title":"Fragile X premutation carriers: Characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction","volume":"23","author":"Brunberg","year":"2002","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1866-1955-6-30","article-title":"Associated features in females with an FMR1 premutation","volume":"6","author":"Wheeler","year":"2014","journal-title":"J. Neurodev. Disord."},{"key":"ref_20","first-page":"331","article-title":"Molecular diagnosis of fragile X syndrome with polymerase chain reaction: Application of a diagnostic protocol in 50 families from northern spain","volume":"54","year":"2001","journal-title":"An. Esp. Pediatr."},{"key":"ref_21","first-page":"49","article-title":"Estimaci\u00f3n de la Prevalencia de Hipotiroidismo en la Comunidad Aut\u00f3noma del Pa\u00eds Vasco a Partir del Consumo de Hormonas Tiroideas (2000\u20132006)","volume":"Volume 5","year":"2007","journal-title":"Farmacia de Atenci\u00f3n Primaria: Publicaci\u00f3n Peri\u00f3dica de Divulgaci\u00f3n YExpresi\u00f3n Cient\u00edfica de la Sociedad Espa\u00f1ola de Farmac\u00e9uticos de Atenci\u00f3n Primaria (SEFAP)"},{"key":"ref_22","unstructured":"Cuadros, J., Llaneza, P., and Mateu, S. (2000). Libro Blanco de la Menopausia en Espa\u00f1a, Menopausia, EMISA."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.maturitas.2014.11.007","article-title":"Spanish consensus on premature menopause","volume":"80","author":"Mendoza","year":"2015","journal-title":"Maturitas"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1086\/374321","article-title":"Fragile X premutation tremor\/ataxia syndrome: Molecular, clinical, and neuroimaging correlates","volume":"72","author":"Jacquemont","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fgene.2014.00260","article-title":"Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): A preliminary study","volume":"5","author":"Allen","year":"2014","journal-title":"Front. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-0031-1280915","article-title":"FMR1 and the continuum of primary ovarian insufficiency","volume":"29","author":"Sullivan","year":"2011","journal-title":"Semin. Reprod. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1261\/rna.206307","article-title":"Analysis of FMR1gene expression in female premutation carriers using robust segmented linear regression models","volume":"13","author":"Poch","year":"2007","journal-title":"RNA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuro.2016.01.008","article-title":"Phenobarbital use and neurological problems in FMR1 premutation carriers","volume":"53","author":"Saldarriaga","year":"2016","journal-title":"Neurotoxicology"},{"key":"ref_29","unstructured":"Osakidetza. Available online: www.osakidetza.euskadi.eus."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.gene.2012.10.016","article-title":"Screening for the presence of FMR1 premutation alleles in women with fibromyalgia","volume":"512","author":"Madrigal","year":"2013","journal-title":"Gene"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s10067-012-2052-y","article-title":"Screening for the presence of FMR1 premutation alleles in a Spanish population with fibromyalgia","volume":"31","author":"Martorell","year":"2012","journal-title":"Clin. Rheumatol"},{"key":"ref_32","unstructured":"Reumatolog\u00eda Cl\u00ednica. Available online: www.reumatologiaclinica.org."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/7\/10\/90\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:33:38Z","timestamp":1760211218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/7\/10\/90"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,21]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10]]}},"alternative-id":["genes7100090"],"URL":"https:\/\/doi.org\/10.3390\/genes7100090","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,21]]}}}